should create some interest, page-7

certainly a favourable/positve article however I am

not fond of the following paragraph:

At the completion of the phase II clinical trial we’d be looking to find partners, but what it also might present is an opportunity for us to raise money and go and complete phase III studies ourselves,” Mr Diamond says, as well as speculating that decent data would make Antisense a takeover target. “That’s something that we will contemplate,” he says.

Just what we need is more dillution, I can only hope

if this does occur the SP is sitting around say 10-20cents (unlikely)

so we don't have to add another 500million shares or

whatever maybe needed to fund phase III.

Though knowing ANP and where the SP currently sits we will

probably still be trading at this ridiculous price of

1.2 - 1.6 cents range and require massive increase in

shares simply to go it alone. Time will tell. GLA